logo Hematology/Oncology Research Studies: Open for Enrollment Date: 10/22/18

Category: ONCOLOGY: EARLY PHASE

Pilot Study of Mitoxantrone in combination with Clofarabine in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma

NCT#/Phase: NCT01842672
Phase 1/2a
IRB#: 2017-037
Description: This study will evalute the maximum tolerated dose and response rate of the combination of mitoxantrone and clofarabine as reinduction therapy for patients with poor risk refractory/relapsed acute leukemia and high grade non-Hodgkin lymphoma (NHL).
Inclusion: Individuals who are <= 30 years of age with relapsed or refractory acute leukemia or NHL.
Enrollment Status: Open for enrollment
Sponsor: New York Medical College
Principal Investigator(s): Jennifer Michlitsch, MD
Contact(s): Anu Agrawal, MD (510-428-3885 x3539)
Jennifer Michlitsch, MD
Study Link: https://clinicaltrials.gov/ct2/show/NCT01842672

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 &bull Phone: (510) 428-3000